XIGDUO Trademark

Trademark Overview

On Thursday, February 2, 2012, a trademark application was filed for XIGDUO with the United States Patent and Trademark Office. The USPTO has given the XIGDUO trademark a serial number of 85532391. The federal status of this trademark filing is REGISTERED AND RENEWED as of Monday, July 8, 2024. This trademark is owned by Bristol-Myers Squibb Company. The XIGDUO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment or prevention of metabolic disorders, namely, diabetes
xigduo

General Information

Serial Number85532391
Word MarkXIGDUO
Filing DateThursday, February 2, 2012
Status800 - REGISTERED AND RENEWED
Status DateMonday, July 8, 2024
Registration Number4708578
Registration DateTuesday, March 24, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 24, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment or prevention of metabolic disorders, namely, diabetes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 7, 2012
Primary Code005
First Use Anywhere DateFriday, November 14, 2014
First Use In Commerce DateFriday, November 14, 2014

Trademark Owner History

Party NameAstrazeneca AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE
Party NameAstrazeneca AB
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressSödertälje SE15185
SE
Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10154
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Tuesday, February 7, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, May 13, 2012ASSIGNED TO EXAMINER
Monday, February 6, 2012NEW APPLICATION ENTERED
Wednesday, June 20, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, July 4, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, May 13, 2012NON-FINAL ACTION WRITTEN
Sunday, May 13, 2012NON-FINAL ACTION E-MAILED
Sunday, May 13, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 25, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 7, 2012ASSIGNED TO LIE
Friday, June 15, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 15, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 15, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 8, 2013SOU TEAS EXTENSION RECEIVED
Tuesday, July 24, 2012PUBLISHED FOR OPPOSITION
Tuesday, July 24, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 18, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, March 7, 2013SOU TEAS EXTENSION RECEIVED
Thursday, March 7, 2013SOU EXTENSION 1 FILED
Thursday, March 7, 2013SOU EXTENSION 1 GRANTED
Saturday, March 9, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 3, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 19, 2014ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, August 8, 2013SOU EXTENSION 2 FILED
Monday, September 9, 2013SOU EXTENSION 2 GRANTED
Friday, September 6, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 10, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 18, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 18, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 18, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 18, 2014SOU TEAS EXTENSION RECEIVED
Tuesday, March 18, 2014SOU EXTENSION 3 FILED
Friday, April 4, 2014SOU EXTENSION 3 GRANTED
Saturday, February 7, 2015STATEMENT OF USE PROCESSING COMPLETE
Saturday, April 5, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 2, 2014SOU TEAS EXTENSION RECEIVED
Tuesday, September 2, 2014SOU EXTENSION 4 FILED
Thursday, September 4, 2014SOU EXTENSION 4 GRANTED
Friday, September 5, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 8, 2014ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, January 26, 2015TEAS STATEMENT OF USE RECEIVED
Monday, January 26, 2015USE AMENDMENT FILED
Thursday, May 6, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, February 13, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, February 14, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 24, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, March 24, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, January 13, 2021TEAS SECTION 8 & 15 RECEIVED
Wednesday, May 5, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, May 5, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, July 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, July 22, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sunday, March 24, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, April 9, 2024TEAS SECTION 8 & 9 RECEIVED
Monday, July 8, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, July 8, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, July 8, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Monday, July 8, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords

xigduo disorders namely diabetes metabolic prevention preparations human treatment pharmaceutical